These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Analysis of tolerance induction using triple chimeric mice: major histocompatibility complex-disparate thymus, hemopoietic cells, and microenvironment. Cui W, Hosaka N, Miyake T, Wang X, Guo K, Cui Y, Li Q, Song C, Feng W, Li Q, Takaki T, Nishida T, Inaba M, Ikehara S. Transplantation; 2008 Apr 27; 85(8):1151-8. PubMed ID: 18431236 [Abstract] [Full Text] [Related]
7. Tolerance to maternal immunoglobulins: resilience of the specific T cell repertoire in spite of long-lasting perturbations. Faure M, Calbo S, Kanellopoulos J, Drapier AM, Cazenave PA, Rueff-Juy D. J Immunol; 1999 Dec 15; 163(12):6511-9. PubMed ID: 10586043 [Abstract] [Full Text] [Related]
8. [Development of HPV16 positive cervical cancer model in the hu-PBL-SCID mouse and its immunological features]. Liang ZX, Cheng Q, Chen HZ, Xie X, Ye DF. Zhonghua Yi Xue Za Zhi; 2004 Sep 02; 84(17):1465-9. PubMed ID: 15500747 [Abstract] [Full Text] [Related]
9. A model of human anti-T-cell monoclonal antibody therapy in SCID mice engrafted with human peripheral blood lymphocytes. Tsuchida M, Brown SA, Tutt LM, Tan J, Seehafer DL, Harris JP, Xun CQ, Thompson JS. Clin Transplant; 1997 Oct 02; 11(5 Pt 2):522-8. PubMed ID: 9361954 [Abstract] [Full Text] [Related]
10. Specific antibody production to a recall or a neoantigen by SCID mice reconstituted with human peripheral blood lymphocytes. Nonoyama S, Smith FO, Ochs HD. J Immunol; 1993 Oct 01; 151(7):3894-901. PubMed ID: 8376809 [Abstract] [Full Text] [Related]
11. Enhancement of BM allografting from C57BL/6 'nude' mice into C3H/HeJ recipients by tolerized T cells from (C57BL/6-->C3H/HeJ) and (C3H/HeJ-->C57BL/6) chimeras. Faktorowich Y, Lapidot T, Lubin I, Reisner Y. Bone Marrow Transplant; 1993 Jul 01; 12(1):15-20. PubMed ID: 8374532 [Abstract] [Full Text] [Related]
12. NOD/SCID mice engrafted with human peripheral blood lymphocytes can be a model for investigating B cells responding to blood group A carbohydrate determinant. Zhou W, Ohdan H, Tanaka Y, Hara H, Tokita D, Onoe T, Asahara T. Transpl Immunol; 2003 Jul 01; 12(1):9-18. PubMed ID: 14551028 [Abstract] [Full Text] [Related]
13. Thymectomy and severe combined immune-deficient bone marrow transplantation eradicates natural antibody of mice to human blood cells. Huppes W, Dijk J, Kinwel-Bohre EP, Van Bekkum DW. Transplantation; 1993 Dec 01; 56(6):1568-9. PubMed ID: 8305084 [No Abstract] [Full Text] [Related]
15. Transfer of idiotypic protein primed allogeneic marrow grafts elicits potent graft-versus-myeloma effects in mice. Zeis M, Steinmann J, Petrela E, Hartung G, Schmitz N, Uharek L. Bone Marrow Transplant; 2001 Feb 01; 27(3):279-85. PubMed ID: 11277175 [Abstract] [Full Text] [Related]